Plain-English translation of NCT06858709 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study investigates whether electroacupuncture—a treatment that uses fine needles with mild electrical stimulation—can help reduce nerve pain and numbness when combined with standard medications for chemotherapy-related nerve damage. About two-thirds of cancer patients experience nerve problems like tingling, numbness, or pain in their hands and feet after chemotherapy, and this trial wants to see if electroacupuncture can make those symptoms better.
Nerve pain from chemotherapy can last for months or years and seriously affects quality of life, but current standard treatments don't work well for everyone. Researchers hope this treatment might offer patients a gentler, additional option with fewer side effects than medication alone.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either real electroacupuncture or a sham (placebo) version, along with your standard nerve pain medications. Both groups receive the same standard care; the difference is whether the acupuncture is real or not. You would attend regular treatment sessions, keep your skin healthy at the treatment sites, and complete questionnaires to track how your symptoms change over time.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China